about
Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasiasMultiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transferEffect of the G375C and G346E achondroplasia mutations on FGFR3 activation.Physical basis behind achondroplasia, the most common form of human dwarfism.Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET.FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism.New evidence for positive selection helps explain the paternal age effect observed in achondroplasiaPhysical-chemical principles underlying RTK activation, and their implications for human disease.The chondrocytic journey in endochondral bone growth and skeletal dysplasia.FGFR3 is a target of the homeobox transcription factor SHOX in limb development.Production of plasma membrane vesicles with chloride salts and their utility as a cell membrane mimetic for biophysical characterization of membrane protein interactions.Pediatric Craniovertebral Junction Surgery.Effect of thanatophoric dysplasia type I mutations on FGFR3 dimerization.The A391E mutation enhances FGFR3 activation in the absence of ligand.Signaling by FGFR in diseaseSignaling by FGFR3 in diseaseSignaling by FGFR3 point mutants in cancerMolecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia.A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors.Novel and Recurrent Mutations in the FGFR3 Gene and Double Heterozygosity Cases in a Cohort of Brazilian Patients with Skeletal Dysplasia.Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
P2860
Q28252023-66FE6D7B-1D54-4CE9-A09D-BDEEF7D80D06Q28486282-37CCB8D5-F78C-401A-BD66-8E04DCBC38ACQ28834399-91BD8C27-1CBA-475C-AF5C-9E2BF7B806BBQ31056899-8393BB32-72DD-480E-82E5-280A8A335068Q34144662-8B55929B-178E-4CE0-8548-F5C840CEEE95Q34441834-178C4A5E-9E58-4E34-892F-05BDE1237FFDQ34787143-02531832-3577-4D09-BA7B-BB679E7C736AQ37193908-6DFAAA77-0994-41CE-85FB-1286B6A2BE67Q37917164-94CB610F-F80B-43CC-8C7D-E2EB3C49DA6AQ38200066-691C3B57-B992-4169-8FCB-0CE4B7993FD8Q39601677-D1A08F9D-5E0C-4563-A900-1F9DEDF2EA14Q41478977-8883C387-AB9B-49BD-853D-9D9540B34AACQ42257932-3983B7B3-8DAC-4306-A062-A17E25ECE152Q42554214-0C929058-9768-4392-B6F2-6D65833DB397Q42749671-FE72F8BC-D860-4082-8AAC-A81653C81854Q45314356-FB52B07F-D326-46A4-9DF7-CF63B36EC09DQ45314373-9178F52B-E819-4539-9B25-CE648A66BDB5Q45314374-8ACE48C5-4FA3-4C83-976F-0C1241226121Q47612372-B833190F-96BE-4A9C-BB6A-0164F24226A0Q50293429-77DFFDCA-B1C9-46E8-AA35-9A6F4E1D1C27Q52624724-3D62124E-360C-46C5-83C7-7F72A37FD52AQ55004516-3E838084-455A-4B5F-8456-5FB49A94029D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FGFR3-related dwarfism and cell signaling.
@en
FGFR3-related dwarfism and cell signaling.
@nl
type
label
FGFR3-related dwarfism and cell signaling.
@en
FGFR3-related dwarfism and cell signaling.
@nl
prefLabel
FGFR3-related dwarfism and cell signaling.
@en
FGFR3-related dwarfism and cell signaling.
@nl
P2093
P2860
P1476
FGFR3-related dwarfism and cell signaling.
@en
P2093
Daisuke Harada
Hiroyuki Tanaka
Yoshiki Seino
Yoshitaka Yamanaka
P2860
P2888
P356
10.1007/S00774-008-0009-7
P577
2008-12-09T00:00:00Z